Virtual Panel Discussion: Demystifying Machine Learning and Artificial Intelligence

Buzzwords like Machine Learning (ML), Artificial Intelligence (AI), Big Data and Industry 4.0 are quite common these days and are regularly thrown at us in newspapers, magazines, TV and podcasts. But what do they really mean?

Definitions may vary, depending on whom you ask. Some of the statements are even sensational: Artificial intelligence (AI) and machine learning (ML) are sometimes demonized as “dark magic” that will soon wipe out hundreds of thousands of jobs. Really?

Seriously: No. In many cases, these buzzwords are just new paraphrases for tried-and-true programs and techniques but adapted to take advantage of higher data availability. For example, the supervised and unsupervised learning at the heart of Machine Learning relies on well-established statistical modeling techniques: regression, classification and clustering.

Both Machine Learning and Artificial Intelligence (AI) applications will provide critical support to make the most of available data that are generated at every level along the value chain – from R&D through to manufacturing and distribution. The clear goal is to drive more value for your organization.

When joining this high-level virtual panel discussion, you will find guidance and first-hand use cases about how to get started with Machine Learning techniques and effectively integrate them in your organizations’ processes.

May 14, 2020 | 10:30 – 12:00 CET
REGISTER TO ATTEND

Meet the speakers:

  • David Meintrup, Ingolstadt University of Applied Sciences
  • Bernard Ennis, Tata Steel
  • Steve King, Rolls-Royce
  • Teena Bonizzi, SABIC

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.